Detalhe da pesquisa
1.
Non-persistence to antihypertensive drug therapy in Lithuania.
Eur J Clin Pharmacol
; 78(10): 1687-1696, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918539
2.
Healthcare professional-led interventions on lifestyle modifications for hypertensive patients - a systematic review and meta-analysis.
BMC Fam Pract
; 22(1): 63, 2021 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820547
3.
Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003-2012.
Medicina (Kaunas)
; 53(4): 259-267, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844562
4.
Hypertension management and drug-related problems. A case report of the 23-year history of Mr. Jonas.
Explor Res Clin Soc Pharm
; 11: 100313, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601158
5.
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Biomed Res Int
; 2023: 9757348, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37065720
6.
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Biomed Res Int
; 2021: 9996193, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676266
7.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535841
8.
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe.
Orphanet J Rare Dis
; 15(1): 277, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032634
9.
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Appl Health Econ Health Policy
; 18(1): 5-16, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696433
10.
Integrative Review of Managed Entry Agreements: Chances and Limitations.
Pharmacoeconomics
; 38(11): 1165-1185, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32734573
11.
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.
Front Pharmacol
; 10: 487, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31139080
12.
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Expert Rev Pharmacoecon Outcomes Res
; 19(3): 251-261, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696372
13.
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Front Public Health
; 6: 328, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568938
14.
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.
Front Pharmacol
; 8: 892, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326583
15.
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.
Front Pharmacol
; 8: 942, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29403372
16.
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Front Pharmacol
; 8: 497, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878667
17.
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Front Pharmacol
; 7: 305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733828
18.
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Expert Rev Clin Pharmacol
; 8(1): 77-94, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25487078
19.
Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies.
Expert Rev Pharmacoecon Outcomes Res
; 16(2): 149-52, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26914489
20.
European countries with small populations can obtain low prices for drugs: Lithuania as a case history.
Expert Rev Pharmacoecon Outcomes Res
; 11(3): 343-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21671703